Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

NCT01045772 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Muckle-Wells Syndrome
Schnitzler Syndrome

Interventions

DRUG: rilonacept

Sponsor

Charite University, Berlin, Germany